G 343 (Oxybutynin Chloride Extended Release 15 mg)
Pill with imprint G 343 is White, Round and has been identified as Oxybutynin Chloride Extended Release 15 mg. It is supplied by Teva Pharmaceuticals USA.
Oxybutynin is used in the treatment of urinary incontinence; urinary frequency; dysuria; neurogenic detrusor overactivity and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 343
Oxybutynin Chloride Extended Release
- Imprint
- G 343
- Strength
- 15 mg
- Color
- White
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-5208
- Inactive Ingredients
-
hypromelloses,
lactose monohydrate,
methacrylic acid,
microcrystalline cellulose,
magnesium silicate,
triethyl citrate
Note: Inactive ingredients may vary.
Related Images for "G 343"
More about oxybutynin
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 377 Reviews
- Drug class: urinary antispasmodics
- FDA Alerts (1)
Consumer resources
- Patient Information
- Oxybutynin transdermal
- Oxybutynin (Advanced Reading)
- Oxybutynin Transdermal (Advanced Reading)
- Other brands
- Ditropan, Ditropan XL, Oxytrol, Gelnique, Anturol
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.